These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12778853)

  • 1. [Evaluation of osteodystrophy parameters in a pre-dialysis unit].
    Barril G; Sanz P; Bardón E; Andrino T; Cigarrán S; Díaz A; Selgas R
    Nefrologia; 2003; 23 Suppl 2():43-6. PubMed ID: 12778853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
    Sforzini S; Viganò MR; Beretta P; Rosa M; d'Amico P; Lomuscio G; Paesani R
    Minerva Med; 1985 Mar; 76(9-10):445-8. PubMed ID: 3982703
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and pattern of renal osteodystrophy in chronic hemodialysis patients: a cross sectional study of 103 patients.
    Buargub MA; Nabulsi MF; Shafeh TA
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):401-7. PubMed ID: 16970264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
    Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
    Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].
    Rojas González AM; Opazo Valenzuela M; Muñoz Navarro S
    Medwave; 2014 Sep; 14(8):e6014. PubMed ID: 25340338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitamin A status of patients with chronic renal failure in relation to renal osteodystrophy].
    Stein G; Abendroth K; Kokot F; Keil E; Schöne S; Wessel G; Fünfstück R; Sperschneider H
    Z Urol Nephrol; 1985 Mar; 78(3):159-65. PubMed ID: 4002896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients.
    Johansen KL; Chertow GM
    J Ren Nutr; 2007 Sep; 17(5):305-13. PubMed ID: 17720099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical and histological spectrum of renal osteodystrophy in Argentina].
    Douthat WG; Garay G; de Arteaga J; Fernández Martín JL; Cannata Andía JB; Massari PU
    Nefrologia; 2003; 23 Suppl 2():47-51. PubMed ID: 12778854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteodystrophy of dialysed patients treated with vitamin D.
    Verberckmoes R; Bouillon R; Krempien B
    Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246
    [No Abstract]   [Full Text] [Related]  

  • 12. Musculoskeletal disorders in hemodialysis patients: different disease clustering according to age and dialysis vintage.
    Hage S; Hage V; El-Khoury N; Azar H; Chelala D; Ziadé N
    Clin Rheumatol; 2020 Feb; 39(2):533-539. PubMed ID: 31701366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relation Between Variability of Intact Parathyroid Hormone, Calcium, and Cardiac Mortality in Hemodialysis Patients.
    Ulusoy S; Ozkan G; Guvercin B; Yavuz A
    Artif Organs; 2016 Nov; 40(11):1078-1085. PubMed ID: 27110947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
    Ziółkowska H; Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E
    J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal bone disease in patients on haemodialysis: biochemical and radiological assessment.
    Lye WC; Lee EJ
    Ann Acad Med Singap; 1992 Nov; 21(6):760-4. PubMed ID: 1295414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of the prevalence of low turn over renal osteodystrophy using biological markers in a peritoneal dialysis population].
    Negri AL; Alvarez Quiroga M; Bravo M; Fradinger E; Jacobo de Marino A; Bogado CE; Zanchetta JR
    Nefrologia; 2001; 21(4):392-4. PubMed ID: 11816516
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence and pattern of renal bone disease in end stage renal disease patients in Ile-Ife, Nigeria.
    Sanusi AA; Arogundade FA; Oladigbo M; Ogini LM; Akinsola A
    West Afr J Med; 2010; 29(2):75-80. PubMed ID: 20544630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol.
    Arora N; Sandroni S; Moles K
    Adv Perit Dial; 1992; 8():62-4. PubMed ID: 1361854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.